ABSTRACT
INTRODUCTION We prospectively evaluated morphologic and functional changes in the carotid arteries of patients treated with unilateral neck radiation therapy (RT) for head and neck cancer.
METHODS Bilateral carotid artery duplex studies were performed at 0, 3, 6, 12, 18 months and 2, 3, 4, and 5 years following RT. Intima media thickness (IMT); global and regional circumferential, as well as radial strain, arterial elasticity, stiffness, and distensibility were calculated.
RESULTS Thirty-eight patients were included. A significant difference in the IMT from baseline between irradiated and unirradiated carotid arteries was detected at 18 months (median, 0.073mm vs -0.003mm; P=0.014), which increased at 3 and 4 years (0.128mm vs 0.013mm, P=0.016, and 0.177mm vs 0.023mm, P=0.0002, respectively). A > 0.073mm increase at 18 months was significantly more common in patients who received concurrent chemotherapy (67% vs 25%; P=0.03). A significant transient change was noted in global circumferential strain between the irradiated and unirradiated arteries at 6 months (median difference, -0.89, P=0.023), which did not persist. No significant differences were detected in the other measures of elasticity, stiffness, and distensibility.
CONCLUSIONS Functional and morphologic changes of the carotid arteries detected by carotid ultrasound, such as changes in global circumferential strain at 6 months and carotid IMT at 18 months, may be useful for the early detection of radiation-induced carotid artery injury, can guide future research aiming to mitigate carotid artery stenosis, and should be considered for clinical surveillance survivorship recommendations after head and neck RT.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The statistical analysis was supported in part by the NIH/NCI Cancer Center Support Grant (award number P30 CA016672) and used the Biostatistics Resource Group. EK is supported in part by NIH/NCI 1R01 HL157273 and CPRIT RP200381 both of which are not related to the current work. Dr. Fuller has received unrelated grants/honoraria from Elekta AB, has received travel support from Philips Medical Systems, and has served in an advisory capacity for Siemens Healthineers.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was approved by the Institutional Research Board of MD Anderson (ClinicalTrials.gov Identifier: NCT02069964).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Conflicts of Interest and Sources of Support: The statistical analysis was supported in part by the NIH/NCI Cancer Center Support Grant (award number P30 CA016672) and used the Biostatistics Resource Group. EK is supported in part by NIH/NCI 1R01 HL157273 and CPRIT RP200381 both of which are not related to the current work. Dr. Fuller has received unrelated grants/honoraria from Elekta AB, has received travel support from Philips Medical Systems, and has served in an advisory capacity for Siemens Healthineers.
Data Availability
All data produced in the present study are available upon reasonable request to the authors
